J. Plantier

发表

Performance of rapid tests for discrimination between HIV‐1 and/or HIV‐2 infections

S. Brunet, A. Gautheret-Dejean, Jonathan Bocobza, 2015, Journal of medical virology.

Evaluation of an Upgraded Version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test for HIV-1 Load Quantification

F. Brun-Vézinet, C. Rouzioux, D. Descamps, 2010, Journal of Clinical Microbiology.

Assessment of multiplex digital droplet RT-PCR as an accurate diagnosis tool for SARS-CoV-2 detection in nasopharyngeal swabs and saliva samples

C. Houdayer, T. Frebourg, K. Cassinari, 2020, medRxiv.

Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses.

F. Barré-Sinoussi, P. Roques, C. Apetrei, 2001, AIDS research and human retroviruses.

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries

V. Calvez, F. Brun-Vézinet, M. Peeters, 2018, The Journal of antimicrobial chemotherapy.

Molecular epidemiology of hepatitis B virus in Dakar, Sénégal

F. Fall, G. Vernet, M. Vray, 2006, Journal of medical virology.

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam

M. Lemoine, K. Lacombe, V. Lemée, 2018, BMC Infectious Diseases.

Evidence of Transmission and Circulation of Deltacron XD Recombinant Severe Acute Respiratory Syndrome Coronavirus 2 in Northwest France

M. Ar Gouilh, J. Plantier, A. Moisan, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Extent of Antigenic Diversity in the V3 Region of the Surface Glycoprotein, gp120, of Human Immunodeficiency Virus Type 1 Group M and Consequences for Serotyping

S. Le Pogam, J. Plantier, F. Barin, 1998, Journal of Virology.

HIV-1 sequences in the epidemic suggest an alternative pathway for the generation of the Long Terminal Repeats

M. Negroni, J. Plantier, Pierre Cappy, 2017, Scientific Reports.

Failures in the detection of HIV p24 antigen with the Determine HIV-1/2 Ag/Ab Combo rapid test.

S. Laperche, J. Plantier, Lionel Leballais, 2012, The Journal of infectious diseases.

First report of transmission of a highly resistant strain of HIV-1 group O.

L. Meyer, J. Plantier, T. Mourez, 2016, AIDS.

A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes

J. Braun, E. Tuaillon, F. Damond, 2003, AIDS.

Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients

I. Étienne, V. Lemée, O. Boyer, 2021, Journal of the American Society of Nephrology : JASN.

V3 Serological Subtyping of Human Immunodeficiency Virus Type 2 Infection Is Not Relevant

F. Brun-Vézinet, F. Damond, J. Plantier, 2001, Journal of Clinical Microbiology.

Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay.

R. Njouom, V. Lemée, J. Plantier, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Virologic Diagnosis and Follow-up of Children Born to Mothers Infected by HIV-1 Group O

V. Ferré, V. Lemée, J. Braun, 2004, Journal of acquired immune deficiency syndromes.

Performance Analysis of Three Commercial Kits Designed for RNA Quantification of HIV-1 Group O Variants

J. Plantier, M. Gueudin, E. Alessandri-Gradt, 2021, Journal of acquired immune deficiency syndromes.

Methicillin-resistant Staphylococcus aureus with the novel mecC gene variant isolated from a cat suffering from chronic conjunctivitis

S. Yerly, H. Fleury, D. Descamps, 2013 .

Higher Specificity of Nucleic Acid Sequence-Based Amplification Isothermal Technology than of Real-Time PCR for Quantification of HIV-1 RNA on Dried Blood Spots

C. Delaugerre, N. Schnepf, M. Vray, 2013, Journal of Clinical Microbiology.

Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification: Usefulness of the Agence Nationale de Recherches sur le SIDA Second-Generation Long Terminal Repeat-Based Real-Time Reverse Transcriptase Polymerase Chain Reaction Test

M. Peeters, C. Rouzioux, L. Ferradini, 2007, Journal of acquired immune deficiency syndromes.

Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains.

C. Rouzioux, L. Meyer, N. Lerolle, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

HIV‐1 non‐group M phenotypic susceptibility to integrase strand transfer inhibitors

C. Charpentier, D. Descamps, J. Plantier, 2017, The Journal of antimicrobial chemotherapy.

First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon.

V. Lemée, J. Plantier, F. Simon, 2010, AIDS.

Diagnosis and Monitoring of HIV-1 Group O-Infected Patients in Cameroun

D. Rousset, J. Plantier, F. Simon, 2010, Journal of acquired immune deficiency syndromes.

Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa

M. Vray, V. Lemée, J. Braun, 2005, AIDS.

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

E. Arts, J. Plantier, D. Tebit, 2016, AIDS research and human retroviruses.

Dried Blood Spot Tests for the Diagnosis and Therapeutic Monitoring of HIV and Viral Hepatitis B and C

P. Van de Perre, E. Tuaillon, F. Taieb, 2020, Frontiers in Microbiology.

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

C. Charpentier, S. Cauchemez, J. Pawlotsky, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Kinetics of relapse after pegylated interferon and ribavirin therapy for chronic hepatitis C

G. Duverlie, P. Mathurin, G. Riachi, 2013, Journal of medical virology.

HIV-1 group N: travelling beyond Cameroon

C. Delaugerre, J. Plantier, F. Simon, 2011, The Lancet.

HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef

F. Kirchhoff, Ravindra K. Gupta, G. Towers, 2011, Retrovirology.

Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain

G. Learn, F. Kirchhoff, B. Hahn, 2017, Journal of Virology.

Differential utilization of CD4 by transmitted/founder and chronic envelope glycoproteins in a MSM HIV-1 subtype B transmission cluster.

A. Moreau, F. Mammano, Olivia Blake, 2020, AIDS.

Simian Immunodeficiency Virus seroreactivity in inhabitants from rural Cameroon frequently in contact with non-human primates.

A. Fontanet, A. Gessain, E. Betsem, 2017, Virology.

V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1

D. Ho, M. Nussenzweig, A. Moreau, 2016, Journal of acquired immune deficiency syndromes.

Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants.

C. Delaugerre, M. Vray, V. Lemée, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.

C. Delaugerre, G. Peytavin, P. Sellier, 2015, AIDS.

Non-M Variants of Human Immunodeficiency Virus Type 1

J. Plantier, F. Simon, T. Mourez, 2013, Clinical Microbiology Reviews.

The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection.

S. Laperche, V. Lemée, J. Plantier, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Cross-group neutralization of HIV-1 and evidence for conservation of the PG9/PG16 epitopes within divergent groups of HIV-1

J. Plantier, F. Barin, F. Simon, 2012, Retrovirology.

A new human immunodeficiency virus derived from gorillas

François Simon, David L Robertson, Jean-Christophe Plantier, 2009, Nature Medicine.

Early phylodynamics analysis of the COVID-19 epidemics in France

Y. Michalakis, S. Alizon, D. Boutolleau, 2020, medRxiv.

Molecular Epidemiology of Simian Immunodeficiency Virus Infection in Wild-Living Gorillas

C. Boesch, P. J. Kranzusch, B. Hahn, 2009, Journal of Virology.

Proceedings of the Frontiers of Retrovirology Conference 2016

R. König, D. Elleder, R. Sachidanandam, 2016, Retrovirology.

V3 serotyping of HIV-1 infection: correlation with genotyping and limitations.

M. Peeters, E. Delaporte, C. Apetrei, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

HIV-1 resistance genotyping on dried serum spots

F. Caron, V. Lemée, J. Plantier, 2005, AIDS.

Performance of the Liaison XL Murex HIV Ab/Ag Test on Clinical Samples Representing Current Epidemic HIV Variants

V. Lemée, J. Plantier, M. Etienne, 2014, Journal of Clinical Microbiology.

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.

C. Rouzioux, P. Frange, Laurent Tran, 2015, The Journal of antimicrobial chemotherapy.

Differential Regulation of NF-κB-Mediated Proviral and Antiviral Host Gene Expression by Primate Lentiviral Nef and Vpu Proteins

C. Van Lint, F. Kirchhoff, B. Hahn, 2015, Cell reports.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

J. Pawlotsky, H. Fleury, G. Duverlie, 2015, Journal of Clinical Microbiology.

Phenotypic Susceptibility to Nonnucleoside Inhibitors of Virion-Associated Reverse Transcriptase From Different HIV Types and Groups

P. Roques, V. Lemée, J. Braun, 2004, Journal of acquired immune deficiency syndromes.

Comparison of Hepatitis C Virus NS5b and 5′ Noncoding Gene Sequencing Methods in a Multicenter Study

J. Pawlotsky, G. Duverlie, J. Izopet, 2005, Journal of Clinical Microbiology.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study

V. Calvez, C. Charpentier, C. Delaugerre, 2017, The Journal of antimicrobial chemotherapy.

New Sensitive One-Step Real-Time Duplex PCR Method for Group A and B HIV-2 RNA Load

C. Rouzioux, D. Descamps, M. Chaix, 2014, Journal of Clinical Microbiology.

HIV-1 and HIV-2 produce different amounts of 2-long terminal repeat circular DNA in vitro

J. Braun, J. Plantier, F. Simon, 2008, AIDS.

Differences in proviral DNA load between HIV-1- and HIV-2-infected patients

F. Brun-Vézinet, G. Chêne, V. Lemée, 2008, AIDS.

Assessment of multiplex digital droplet RT-PCR as a diagnostic tool for SARS-CoV-2 detection in nasopharyngeal swabs and saliva samples

C. Houdayer, T. Frebourg, K. Cassinari, 2020, Clinical chemistry.

Genotypic resistance profiles of HIV-2-treated patients in West Africa

C. Charpentier, F. Brun-Vézinet, F. Dabis, 2014, AIDS.

Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort

Y. Yazdanpanah, J. Timsit, F. Raffi, 2021, Proceedings of the National Academy of Sciences.

Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon

D. Rousset, J. Plantier, T. Mourez, 2017, Retrovirology.

Monitoring HIV-1 Subtype Distribution

M. Peeters, J. Plantier, F. Barin, 2002 .

Viral Etiology of Respiratory Tract Infections in Children at the Pediatric Hospital in Ouagadougou (Burkina Faso)

S. Ouédraogo, C. Marguet, J. Plantier, 2014, PloS one.

Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.

F. Brun-Vézinet, D. Robertson, C. Apetrei, 2001, Virology.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Wild Mandrillus sphinx Are Carriers of Two Types of Lentivirus

L. White, D. Robertson, B. Hahn, 2001, Journal of Virology.

HIV type 1 diversity in France, 1999-2001: molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs.

B. Masquelier, H. Fleury, P. Roques, 2003, AIDS research and human retroviruses.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

M. Van Ranst, J. Izopet, D. Roulot, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014–2015

T. Bedford, L. Ferradini, B. Roche, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting

C. Delaugerre, S. Chevret, W. Rozenbaum, 2010, PloS one.

The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon

G. Lachenal, D. Robertson, Felix Feyertag, 2015, PLoS pathogens.

Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02

C. Delaugerre, C. Rouzioux, L. Meyer, 2011, AIDS.

Detection of numerous HIV-1/MO recombinants in France

V. Lemée, M. Chaix, E. Gault, 2018, AIDS.

A Pan-HIV Strategy for Complete Genome Sequencing

C. Brennan, J. Plantier, J. Yamaguchi, 2015, Journal of Clinical Microbiology.

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2013, The Journal of antimicrobial chemotherapy.

French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002

F. Brun-Vézinet, P. André, B. Masquelier, 2005, Journal of acquired immune deficiency syndromes.

Characteristics of Patients Recently Infected with HIV-1 Non-B Subtypes in France: a Nested Study within the Mandatory Notification System for New HIV Diagnoses

A. Moreau, S. Brunet, F. Lot, 2014, Journal of Clinical Microbiology.

Performance of cepheid GeneXpert HIV-1 viral load plasma assay to accurately detect treatment failure: a clinical meta-analysis.

Youyi Fong, Jilian A Sacks, Mercedes Perez Gonzalez, 2019, AIDS.

Plasma RNA quantification and HIV-1 divergent strains.

J. Braun, F. Damond, J. Plantier, 2003, Journal of acquired immune deficiency syndromes.

Sequence and Functional Analysis of the Envelope Glycoproteins of Hepatitis C Virus Variants Selectively Transmitted to a New Host

B. Giraudeau, E. Blanchard, A. Moreau, 2013, Journal of Virology.

New Host Virus Variants Selectively Transmitted to a Envelope Glycoproteins of Hepatitis C Sequence and Functional Analysis of the

E. Blanchard, A. Moreau, P. Roingeard, 2013 .

Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration

D. Minta, F. Dabis, C. Rouzioux, 2015, PloS one.

Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir

C. Charpentier, D. Descamps, J. Plantier, 2018, The Journal of antimicrobial chemotherapy.

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2010, The Journal of antimicrobial chemotherapy.

Evaluation of four commercial extraction-quantification systems to monitor EBV or CMV viral load in whole blood.

J. Plantier, M. Gueudin, A. Gicquel, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2

R. Apps, F. Kirchhoff, B. Hahn, 2020, mBio.

Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France

C. Charpentier, C. Delaugerre, Felix Feyertag, 2013, AIDS.

Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas

F. Jardin, A. Stamatoullas, H. Lanic, 2021, Haematologica.

Interlaboratory quality control of total HIV‐1 DNA load measurement for multicenter reservoir studies

C. Delaugerre, C. Rouzioux, K. Sauné, 2017, Journal of medical virology.

Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France.

J. Desenclos, P. Bernillon, F. Lot, 2007, The Journal of infectious diseases.

Prevalence of HIV-1 Drug Resistance in Treated Patients: A French Nationwide Study

F. Brun-Vézinet, C. Delaugerre, S. Yerly, 2007, Journal of acquired immune deficiency syndromes.

Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic

J. Desenclos, A. Moreau, S. Brunet, 2006, Journal of medical virology.

Development and Evaluation of a DNA Enzyme Immunoassay Method for env Genotyping of Subtypes A through G of Human Immunodeficiency Virus Type 1 Group M, with Discrimination of the Circulating Recombinant Forms CRF01_AE and CRF02_AG

F. Brun-Vézinet, M. Peeters, E. Delaporte, 2002, Journal of Clinical Microbiology.

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

É. Oksenhendler, C. Katlama, D. Neau, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients

I. Étienne, V. Lemée, O. Boyer, 2021, Kidney International.

Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients

V. Lemée, D. Guerrot, J. Plantier, 2022, American Journal of Transplantation.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.

C. Delaugerre, S. Yerly, B. Masquelier, 2013, The Journal of antimicrobial chemotherapy.

HIV-1 Non-Group M Strains and ART

J. Plantier, A. Moisan, E. Alessandri-Gradt, 2023, Viruses.

A New Real-Time Quantitative PCR for Diagnosis and Monitoring of HIV-1 Group O Infection

V. Lemée, J. Plantier, M. Gueudin, 2011, Journal of Clinical Microbiology.

Plasma viral RNA assay in HIV-1 group O infection by real-time PCR.

P. Roques, F. Damond, J. Plantier, 2003, Journal of virological methods.

First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022

V. Calvez, Y. Yazdanpanah, J. Pawlotsky, 2022, Infectious diseases now.

Performance evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus in Cameroon

R. Njouom, J. Plantier, P. Ngoupo, 2018, BMC Research Notes.

Evaluation of the Roche Cobas TaqMan and Abbott RealTime Extraction-Quantification Systems for HIV-1 Subtypes

T. Bourlet, M. Vray, V. Lemée, 2007, Journal of acquired immune deficiency syndromes.

High HIV Type 1 prevalence and wide genetic diversity with dominance of recombinant strains but low level of antiretroviral drug-resistance mutations in untreated patients in northeast Gabon, Central Africa.

P. Roques, M. Kazanji, M. Caron, 2009, AIDS research and human retroviruses.

Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients

I. Étienne, V. Lemée, D. Guerrot, 2021, Clinical kidney journal.

Comparative immuno-virological and clinical responses to antiretroviral therapy between HIV-1 group O- and HIV-1 group M-infected patients (ANRS 12168 DynaMO study).

E. Delaporte, J. Dumortier, D. Rousset, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

C. Charpentier, C. Delaugerre, J. Pawlotsky, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 Group O Integrase Displays Lower Enzymatic Efficiency and Higher Susceptibility to Raltegravir than HIV-1 Group M Subtype B Integrase

M. Wainberg, B. Brenner, D. Moisi, 2014, Antimicrobial Agents and Chemotherapy.

Impact of HIV-1 Group O Genetic Diversity on Genotypic Resistance Interpretation by Algorithms Designed for HIV-1 Group M

C. Charpentier, F. Damond, J. Plantier, 2011, Journal of acquired immune deficiency syndromes.

Baseline Genotypic and Phenotypic Susceptibilities of HIV-1 Group O to Enfuvirtide

C. Charpentier, F. Brun-Vézinet, D. Descamps, 2010, Antimicrobial Agents and Chemotherapy.

Evaluation of Analytical and Clinical Performance and Usefulness in a Real-Life Hospital Setting of Two in-House Real-Time RT-PCR Assays to Track SARS-CoV-2 Variants of Concern

F. Lecoquierre, Steeve Fourneaux, J. Plantier, 2023, Viruses.

Investigation of outbreak cases infected with the SARS-CoV-2 B.1.640 variant in a fully vaccinated elderly population, Normandy, France, November to December 2021

J. Plantier, M. Gueudin, A. Moisan, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendors

C. Delaugerre, V. Lemée, M. Chaix, 2018, EBioMedicine.

Census and Analysis of Persistent False-Negative Results in Serological Diagnosis of Human Immunodeficiency Virus Type 1 Group O Infections

D. Rousset, C. Henquell, V. Lemée, 2009, Journal of Clinical Microbiology.

Unequal detection of HIV type 1 group O infection by simple rapid tests.

J. Huraux, V. Lemée, A. Gautheret-Dejean, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

V. Calvez, C. Charpentier, J. Izopet, 2019, The Journal of antimicrobial chemotherapy.

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.

V. Calvez, C. Delaugerre, S. Yerly, 2013, International journal of antimicrobial agents.

Comparative RNA Quantification of HIV-1 Group M and Non-M With the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR Assays

C. Delaugerre, J. Molina, M. Vray, 2011, Journal of acquired immune deficiency syndromes.

New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017

V. Calvez, P. Bellecave, D. Descamps, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Monitoring of HIV-1 resistance in Tunisia (North Africa) with a dried plasma spot strategy.

J. Plantier, F. Simon, A. Letaief, 2008, Journal of acquired immune deficiency syndromes.

First evidence of transmission of an HIV-1 M/O intergroup recombinant virus

R. Njouom, J. Plantier, T. Mourez, 2015, AIDS.

HIV contamination of commercial PCR enzymes raises the importance of quality control of low-cost in-house genotypic HIV drug resistance tests

M. Peeters, J. Plantier, M. Monleau, 2010, Antiviral therapy.

New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification

C. Rouzioux, F. Collin, D. Descamps, 2017, Journal of Clinical Microbiology.

HIV-2 Surveillance with Next-Generation Sequencing Reveals Mutations in a Cytotoxic Lymphocyte-Restricted Epitope Involved in Long-Term Nonprogression.

C. Brennan, G. Cloherty, J. Plantier, 2016, AIDS research and human retroviruses.

Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.

V. Calvez, C. Charpentier, C. Delaugerre, 2012, The Journal of antimicrobial chemotherapy.

Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 Variants

Jean-Christophe Plantier, V. Lemée, J. Plantier, 2016, Journal of acquired immune deficiency syndromes.

Multi-site clinical evaluation of the Xpert(®) HIV-1 viral load assay.

A. Wu, K. Templeton, J. Plantier, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon

D. Rousset, J. Plantier, F. Simon, 2017, Retrovirology.

RNA amplification of the HIV‐1 Pol and env regions on dried serum and plasma spots

S. Brunet, J. Plantier, F. Barin, 2008, HIV medicine.

Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients

C. Rouzioux, N. Meda, T. Kagoné, 2016, Journal of Clinical Microbiology.

Use of Reverse Transcription-PCR-Based Assays for Quantification of HIV-1 in Dried Blood Spots Requires Specific HIV-1 RNA Isolation for Monitoring of Antiretroviral Treatment Efficiency

C. Rouzioux, D. Descamps, F. Rouet, 2014, Journal of Clinical Microbiology.

Short Communication: Characterization of a New HIV-1 Group N Isolate Originating from a Cameroonian Patient.

R. Njouom, J. Plantier, S. Sadeuh-Mba, 2018, AIDS research and human retroviruses.

HIV-1 group P infection: towards a dead-end infection?

D. Robertson, Felix Feyertag, V. Lemée, 2018, AIDS.

Integrase polymorphism and HIV-1 group O diversity.

P. Roques, B. Roquebert, D. Rousset, 2008, AIDS.

Algorithm-Based Prediction of HIV-1 Subtype D Coreceptor Use

J. Izopet, V. Ferré, S. Raymond, 2013, Journal of Clinical Microbiology.

Proceedings of the Frontiers of Retrovirology Conference 2016

Sebastian A. Wagner, R. König, D. Elleder, 2016, Retrovirology.

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007 – 12: impact on susceptibility to ﬁrst-line strategies

C. Rouzioux, P. Frange, Laurent Tran, 2015 .

HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.

S. Yerly, B. Masquelier, H. Fleury, 2013, The Journal of antimicrobial chemotherapy.

HIV-1 sequences in the epidemic suggest an alternative pathway for the generation of the Long Terminal Repeats

M. Negroni, J. Plantier, Pierre Cappy, 2017, Scientific Reports.

A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants

J. Plantier, M. Gueudin, Pierre Cappy, 2016, Journal of Clinical Microbiology.

HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir.

C. Charpentier, D. Descamps, Q. Le Hingrat, 2021, The Journal of antimicrobial chemotherapy.

HIV-1 Group O Resistance Against Integrase Inhibitors

M. Wainberg, B. Brenner, D. Moisi, 2015, Journal of Acquired Immune Deficiency Syndromes.

Raltegravir-based regimens are effective in HIV-1 group O-infected patients.

J. Plantier, V. Daneluzzi, D. Batisse, 2012, Journal of acquired immune deficiency syndromes.

[Virological diagnosis of lower respiratory tract infections].

S. Pillet, J. Plantier, M. Gueudin, 2021, Revue des maladies respiratoires.

Are Confirmatory Assays Reliable for HIV-1/HIV-2 Infection Differentiation? A Multicenter Study

A. Gautheret-Dejean, Jonathan Bocobza, F. Damond, 2023, Journal of clinical microbiology.

Virological response to integrase strand transfer inhibitor-based antiretroviral combinations in HIV-1 group O-infected patients.

J. Plantier, E. Alessandri-Gradt, G. Unal, 2019, AIDS.

[Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data].

D. Descamps, V. Lemée, F. Damond, 2010, Medecine et maladies infectieuses.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.

Subtype D Coreceptor Use Algorithm-Based Prediction of HIV-1

J. Izopet, S. Raymond, J. Plantier, 2014 .

[Respiratory syncytial virus (RSV) infections in the pediatric teaching hospital Charles de Gaulle of Ouagadougou, Burkina Faso].

C. Marguet, J. Plantier, A. Vabret, 2016, Bulletin de la Societe de pathologie exotique.

Generic screening test for HIV infection.

V. Lemée, J. Plantier, F. Simon, 2006, AIDS (London).

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.

V. Calvez, C. Delaugerre, S. Yerly, 2008, The Journal of antimicrobial chemotherapy.

Rapid Discrimination between Human Immunodeficiency Virus Type 2 Groups A and B by Real-Time PCR

V. Lemée, F. Damond, J. Plantier, 2004, Journal of Clinical Microbiology.

Fabienne de and B by Real-Time PCR Immunodeficiency Virus Type 2 Groups A Rapid Discrimination between Human

V. Lemée, F. Damond, J. Plantier, 2004 .